Skip to main content
NCBI home page
Gut logoLink to Gut
. 1985 Apr;26(4):359–363. doi: 10.1136/gut.26.4.359

Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

D S Collier, J A Pain
PMCID: PMC1432521  PMID: 3979908

Abstract

A retrospective study is reported in which the ingestion of non-steroidal anti-inflammatory drugs (NSAID) in 269 patients with perforated peptic ulceration and 269 age/sex matched controls admitted between 1973-1982 was compared. A highly significant statistical difference was found (p less than 0.001) in those aged over 65. There was no statistical difference, however, in those aged under 65. Furthermore we have shown a highly statistically significant correlation (p less than 0.0001) between the annual number of patients aged over 65 with perforated peptic ulcers taking NSAID and the annual number of prescriptions issued for these drugs in the region. No such correlation was found for patients aged under 65 years. We suggest that the elderly especially women are unduly susceptible to NSAID associated peptic ulcer perforation, and discuss factors that may account for this.

Full text

PDF
359

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolton J. P., Palmer D., Cohen M. M. Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Am J Dig Dis. 1978 Apr;23(4):359–364. doi: 10.1007/BF01072421. [DOI] [PubMed] [Google Scholar]
  2. Brown R. C., Langman M. J., Lambert P. M. Hospital admissions for peptic ulcer during 1958-72. Br Med J. 1976 Jan 3;1(6000):35–37. doi: 10.1136/bmj.1.6000.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chaudhury T. K., Jacobson E. D. Prostaglandin cytoprotection of gastric mucosa. Gastroenterology. 1978 Jan;74(1):58–63. [PubMed] [Google Scholar]
  4. Coggon D., Lambert P., Langman M. J. 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet. 1981 Jun 13;1(8233):1302–1304. doi: 10.1016/s0140-6736(81)92470-3. [DOI] [PubMed] [Google Scholar]
  5. Dark J. H., MacArthur K. Perforated peptic ulcer in south-west Scotland 1966-1980. J R Coll Surg Edinb. 1983 Jan;28(1):19–23. [PubMed] [Google Scholar]
  6. Duggan J. M. Aspirin ingestion and perforated peptic ulcer. Gut. 1972 Aug;13(8):631–633. doi: 10.1136/gut.13.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ippoliti A. F., Isenberg J. I., Maxwell V., Walsh J. H. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology. 1976 Apr;70(4):488–491. [PubMed] [Google Scholar]
  8. Jorgensen T. G. Drug consumption before perforation of peptic ulcer. Br J Surg. 1977 Apr;64(4):247–249. doi: 10.1002/bjs.1800640406. [DOI] [PubMed] [Google Scholar]
  9. Kauffman G. L., Jr, Aures D., Grossman M. I. Intravenous indomethacin and aspirin reduce basal gastric mucosal blood flow in dogs. Am J Physiol. 1980 Feb;238(2):G131–G134. doi: 10.1152/ajpgi.1980.238.2.G131. [DOI] [PubMed] [Google Scholar]
  10. Kurata J. H., Elashoff J. D., Grossman M. I. Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleeding. Gastroenterology. 1982 Feb;82(2):373–376. [PubMed] [Google Scholar]
  11. Langman M. J. Epidemiological evidence for the association of aspirin and acute gastrointestinal bleeding. Gut. 1970 Jul;11(7):627–634. doi: 10.1136/gut.11.7.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Langman M. J. What is happening to peptic ulcer? Br Med J (Clin Res Ed) 1982 Apr 10;284(6322):1063–1064. doi: 10.1136/bmj.284.6322.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Main I. H., Whittle B. J. Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br J Pharmacol. 1975 Feb;53(2):217–224. doi: 10.1111/j.1476-5381.1975.tb07351.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Menguy R., Desbaillets L. Influence of phenylbutazone on gastric secretion of mucus. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1108–1111. doi: 10.3181/00379727-125-32288. [DOI] [PubMed] [Google Scholar]
  15. O'Malley K., Crooks J., Duke E., Stevenson I. H. Effect of age and sex on human drug metabolism. Br Med J. 1971 Sep 11;3(5775):607–609. doi: 10.1136/bmj.3.5775.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. PULVERTAFT C. N. Peptic ulcer in twon and country. Br J Prev Soc Med. 1959 Jul;13:131–138. doi: 10.1136/jech.13.3.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Paffenbarger R. S., Jr, Wing A. L., Hyde R. T. Letter: Coffee, cigarettes and peptic ulcer. N Engl J Med. 1974 May 9;290(19):1091–1091. [PubMed] [Google Scholar]
  18. Parbhoo S. P., Johnston I. D. Effects of oestrogens and progestogens on gastric secretion in patients with duodenal ulcer. Gut. 1966 Dec;7(6):612–618. doi: 10.1136/gut.7.6.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rees W. D., Turnberg L. A. Reappraisal of the effects of aspirin on the stomach. Lancet. 1980 Aug 23;2(8191):410–413. doi: 10.1016/s0140-6736(80)90452-3. [DOI] [PubMed] [Google Scholar]
  20. Robert A., Nezamis J. E., Lancaster C., Hanchar A. J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979 Sep;77(3):433–443. [PubMed] [Google Scholar]
  21. Robert A., Nezamis J. E., Phillips J. P. Inhibition of gastric secretion by prostaglandins. Am J Dig Dis. 1967 Oct;12(10):1073–1076. doi: 10.1007/BF02233268. [DOI] [PubMed] [Google Scholar]
  22. Russel R. I., Williamson J. M., Goldberg A., Wares E. Ascorbic-acid levels in leucocytes of patients with gastrointestinal haemorrhage. Lancet. 1968 Sep 14;2(7568):603–606. doi: 10.1016/s0140-6736(68)90698-3. [DOI] [PubMed] [Google Scholar]
  23. Rydning A., Berstad A., Aadland E., Odegaard B. Prophylactic effect of dietary fibre in duodenal ulcer disease. Lancet. 1982 Oct 2;2(8301):736–739. doi: 10.1016/s0140-6736(82)90922-9. [DOI] [PubMed] [Google Scholar]
  24. SUSSER M., STEIN Z. Civilisation and peptic ulcer. Lancet. 1962 Jan 20;1(7221):115–119. [PubMed] [Google Scholar]
  25. Sanders R. Incidence of perforated duodenal and gastric ulcer in Oxford. Gut. 1967 Feb;8(1):58–63. doi: 10.1136/gut.8.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Solomon T. E., Jacobson E. D. Cigarette smoking and duodenal-ulcer disease. N Engl J Med. 1972 Jun 1;286(22):1212–1213. doi: 10.1056/NEJM197206012862211. [DOI] [PubMed] [Google Scholar]
  27. TRUELOVE S. C. Stilboestrol, phenobarbitone, and diet in chronic duodenal ulcer. A factorial therapeutic trial. Br Med J. 1960 Aug 20;2(5198):559–566. doi: 10.1136/bmj.2.5198.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Thompson M. R. Indomethacin and perforated duodenal ulcer. Br Med J. 1980 Feb 16;280(6212):448–448. doi: 10.1136/bmj.280.6212.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Whittaker J. A., Evans D. A. Genetic control of phenylbutazone metabolism in man. Br Med J. 1970 Nov 7;4(5731):323–328. doi: 10.1136/bmj.4.5731.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wilson D. E., Phillips C., Levine R. A. Inhibition of gastric secretion in man by prostaglandin A. Gastroenterology. 1971 Aug;61(2):201–206. [PubMed] [Google Scholar]
  31. Wilson D. E., Winnan G., Quertermus J., Tao P. Effects of an orally administered prostaglandin analogue (16, 16-dimethyl prostaglandin E2) on human gastric secretion. Gastroenterology. 1975 Sep;69(3):607–611. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES